These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6456424)

  • 21. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
    Xu ZY
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on T and B lymphocytes in rats bearing methylcholanthrene-induced tumor.
    Klobusická M; Kalafut F; Novotná L
    Neoplasma; 1978; 25(6):667-77. PubMed ID: 313020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells.
    Fernandez-Cruz E; Gilman SC; Feldman JD
    J Immunol; 1982 Sep; 129(3):1324-8. PubMed ID: 6213711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
    Fernandez-Cruz E; Gilman SC; Feldman JD
    J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for interaction between T cell populations of tumor-bearing and normal mice in immune suppression.
    Ingenito GG; Calkins CE
    J Immunol; 1981 Sep; 127(3):1236-40. PubMed ID: 6455472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunosuppressive phenomena in experimental tumor systems (author's transl)].
    Reme TX
    Pathol Biol (Paris); 1977 Dec; 25(10):735-40. PubMed ID: 349487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tumor growth on migratory properties of T lymphocytes in rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1980; 27(6):675-82. PubMed ID: 6973097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies.
    Ben-Hur H; Gurevich P; Zion H; Berman V; Tendler Y; Sandler B; Zinder O; Zusman I
    Anticancer Res; 1998; 18(1A):273-81. PubMed ID: 9568090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
    Kumar RK; Lykke AW; Penny R
    J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of diminished splenic responses to phytohemagglutinin and concanavalin A in adjuvant-induced disease by virazole: possible pathogenetic role of a virus and suppressor cells.
    Kapusta MH; Young-Rodenchuk M; Kourounakis L
    J Rheumatol; 1979; 6(5):507-18. PubMed ID: 160459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.
    Pope BL; Whitney RB; Levy JG; Kilburn DG
    J Immunol; 1976 May; 116(5):1342-6. PubMed ID: 1270799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of complement receptor-bearing cells in the spleens of tumor-bearing mice.
    Epstein RS; Lopez DM; Sigel MM; Ross GD
    J Immunol; 1978 Oct; 121(4):1524-7. PubMed ID: 308966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of murine tumors upon delayed hypersensitivity to dinitrochlorobenzene. III. In vivo activity of the nonspecific suppressor cell.
    Jessup JM; Macek CM; Kahan BD; Pellis NR
    J Immunol; 1981 Nov; 127(5):2183-7. PubMed ID: 6457866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state.
    Tanaka K; Koga Y; Taniguchi K; Nomoto K
    Cancer Res; 1987 Apr; 47(8):2136-41. PubMed ID: 3493841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.